Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption
暂无分享,去创建一个
Bryan R. Smith | Brad J. Wood | M. Proschan | D. Hammoud | Z. Grossman | A. Nath | K. Huik | F. Maldarelli | C. Millo | C. Lau | Ana M Ortega-Villa | Brad J Wood | Catherine A. Seamon | B. Chimukangara | Thuy Nguyen | Erin P. Madeen | Catherine A Seamon | W. N. Wulan | Matthew A Adan | Jessica Earhart | A. Savramis | Lindsey R. Adams | Mary-Elizabeth Zipparo | E. Madeen | Ana M. Ortega-Villa | M. Zipparo
[1] J. Mascola,et al. First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody , 2022, Nature Communications.
[2] R. Boellaard,et al. 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[3] R. Slart,et al. Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica , 2021, Rheumatology.
[4] Y. Yeh,et al. Shock-and-kill versus block-and-lock: Targeting the fluctuating and heterogeneous HIV-1 gene expression , 2021, Proceedings of the National Academy of Sciences.
[5] D. Lauffenburger,et al. Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features , 2021, mBio.
[6] P. Price,et al. Total-Body PET Imaging in Infectious Diseases. , 2020, PET clinics.
[7] J. Dorfman,et al. author-version of: Compartmentalization and clonal amplification of HIV-1 in the male genital tract characterized using next-generation sequencing , 2022 .
[8] S. Hughes,et al. HIV-1 Viremia Not Suppressible By Antiretroviral Therapy Can Originate from Large T-Cell Clones Producing Infectious Virus , 2020, bioRxiv.
[9] Z. Debyser,et al. Block-And-Lock Strategies to Cure HIV Infection , 2020, Viruses.
[10] R. Bosch,et al. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared to men. , 2019, AIDS.
[11] S. Q. Brunetto,et al. Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma , 2019, Scientific Reports.
[12] S. Hughes,et al. HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy. , 2019, The Journal of clinical investigation.
[13] M. Beg,et al. Quantifying brain metabolism from FDG‐PET images into a probability of Alzheimer's dementia score , 2019, Human brain mapping.
[14] A. Lazzarin,et al. Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study). , 2019, The Journal of antimicrobial chemotherapy.
[15] J. Mullins,et al. Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression. , 2019, AIDS research and human retroviruses.
[16] T. Chun,et al. Effect of Anti‐CD4 Antibody UB‐421 on HIV‐1 Rebound after Treatment Interruption , 2019, The New England journal of medicine.
[17] B. Walker,et al. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. , 2019, The lancet. HIV.
[18] L. Trautmann,et al. Modeling HIV-1 Latency Using Primary CD4+ T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy , 2019, Journal of Virology.
[19] L. Morris,et al. Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract , 2019, Journal of Virology.
[20] D. Hammoud,et al. Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND) , 2019, Current HIV/AIDS Reports.
[21] R. Siliciano,et al. A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses , 2019, Nature.
[22] Cornelis H. Slump,et al. Repeatability of 18F‐FDG PET radiomic features: A phantom study to explore sensitivity to image reconstruction settings, noise, and delineation method , 2018, Medical physics.
[23] F. Maldarelli,et al. The role of integration and clonal expansion in HIV infection: live long and prosper , 2018, Retrovirology.
[24] Bryan R. Smith,et al. Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals , 2018, Neurology.
[25] L. Dodd,et al. Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Human Immunodeficiency Virus–Associated Immune Reconstitution Inflammatory Syndrome , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] L. Dodd,et al. Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation , 2018, Journal of Neuroinflammation.
[27] M. St. Claire,et al. Total body CD4+ T cell dynamics in treated and untreated SIV infection revealed by in vivo imaging. , 2018, JCI insight.
[28] E. Connick,et al. The B-Cell Follicle in HIV Infection: Barrier to a Cure , 2018, Front. Immunol..
[29] K. Busman-Sahay,et al. Next-generation in situ hybridization approaches to define and quantify HIV and SIV reservoirs in tissue microenvironments , 2018, Retrovirology.
[30] R. Dierckx,et al. The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases , 2017, Nuclear Medicine and Molecular Imaging.
[31] A. Kjaer,et al. Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 Patients , 2017, The Journal of Nuclear Medicine.
[32] G. Learn,et al. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. , 2016, The New England journal of medicine.
[33] B. Barlogie,et al. Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma , 2016, Clinical Cancer Research.
[34] Michael T. Lu,et al. Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection. , 2016, JAMA cardiology.
[35] Nico Pfeifer,et al. HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption , 2016, Nature.
[36] A. Blaxhult,et al. Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels , 2016, BMC Infectious Diseases.
[37] F. Vaida,et al. Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy. , 2016, The Journal of infectious diseases.
[38] M. Lederman,et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption , 2015, AIDS.
[39] R. Slart,et al. Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis , 2015, Medicine.
[40] A. Scarsbrook,et al. FDG PET/CT in infection and inflammation--current and emerging clinical applications. , 2015, Clinical radiology.
[41] Y. Sakamoto,et al. Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer , 2015, Surgery Today.
[42] A. Haase,et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.
[43] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[44] D. Podzamczer,et al. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. , 2014, The Lancet. Infectious diseases.
[45] J. Mellors,et al. Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy , 2014, PLoS pathogens.
[46] Steve Kaye,et al. Short-course antiretroviral therapy in primary HIV infection. , 2013, The New England journal of medicine.
[47] Bradford J. Wood,et al. Multimodality Image Fusion–Guided Procedures: Technique, Accuracy, and Applications , 2012, CardioVascular and Interventional Radiology.
[48] M. Merino,et al. Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology. , 2012, Journal of vascular and interventional radiology : JVIR.
[49] S Spudich,et al. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. , 2012, Cold Spring Harbor perspectives in medicine.
[50] A. Haase,et al. Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy , 2012, PLoS pathogens.
[51] R. Lhommel,et al. HIGH FDG UPTAKE ON FDG-PET SCAN IN HIV-1 INFECTED PATIENT WITH ADVANCED DISEASE , 2011, Acta clinica Belgica.
[52] Samuel Kadoury,et al. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. , 2011, Radiology.
[53] T Reunala,et al. Patient‐Oriented SCORAD (PO‐SCORAD): a new self‐assessment scale in atopic dermatitis validated in Europe , 2011, Allergy.
[54] Sheng Xu,et al. Clinical utility of real-time fusion guidance for biopsy and ablation. , 2011, Journal of vascular and interventional radiology : JVIR.
[55] C. Rouzioux,et al. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir , 2010, Journal of medical virology.
[56] R. Schooley,et al. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. , 2010, The Journal of infectious diseases.
[57] Ankur Kapoor,et al. Navigation systems for ablation. , 2010, Journal of vascular and interventional radiology : JVIR.
[58] T. Murakami,et al. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.
[59] Bradford J Wood,et al. Image-guided adrenal and renal biopsy. , 2010, Techniques in vascular and interventional radiology.
[60] M. Hirsch,et al. Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment , 2009, AIDS.
[61] G. Lucignani,et al. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[62] J. Estes. Role of collagen deposition in lymphatic tissues and immune reconstruction during HIV-1 and SIV infections , 2009, Current HIV/AIDS reports.
[63] M. McKenna,et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[64] B. Wigdahl,et al. HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination , 2008, PLoS pathogens.
[65] A. Haase,et al. The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. , 2008, Seminars in immunology.
[66] B. Reider. Live Long and Prosper , 2008, The American journal of sports medicine.
[67] Joseph A Kovacs,et al. ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia , 2007, PLoS pathogens.
[68] J Darbyshire,et al. CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.
[69] Richard Davey,et al. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation , 2006, AIDS.
[70] C. Rouzioux,et al. Structured Treatment Interruptions in Primary HIV-1 Infection: The ANRS 100 PRIMSTOP Trial , 2005, Journal of acquired immune deficiency syndromes.
[71] R. Hawkins,et al. Advances in positron emission tomography imaging for the GI tract. , 2002, Gastrointestinal endoscopy.
[72] D Delbeke,et al. Positron emission tomography imaging in oncology. , 2001, Radiologic clinics of North America.
[73] R. Siliciano,et al. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection. , 2000, The Journal of infectious diseases.
[74] M Schwaiger,et al. Quantitative assessment of tumor metabolism using FDG-PET imaging. , 2000, Nuclear medicine and biology.
[75] M. Saag,et al. Recurrence of the Acute HIV Syndrome after Interruption of Antiretroviral Therapy in a Patient with Chronic HIV Infection: A Case Report , 2000, Annals of Internal Medicine.
[76] R. Pyzalski,et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques. , 2000, Virology.
[77] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[78] L. Staudt,et al. Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression , 1996, Journal of virology.
[79] Robert F. Siliciano,et al. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency , 1995, Nature Medicine.
[80] K. Maull,et al. Cholecystectomy: to drain or not to drain. A randomized prospective study of 200 patients. , 1978, The Journal of surgical research.
[81] The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption: Erratum. , 2016, AIDS.
[82] C. B. Hare,et al. The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. , 2012, The Journal of infectious diseases.
[83] Baris Turkbey,et al. Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. , 2012, Urology.
[84] G. Shaw,et al. HIV transmission. , 2012, Cold Spring Harbor perspectives in medicine.
[85] B. Thiers,et al. CD4+ Count–Guided Interruption of Antiretroviral Treatment , 2007 .
[86] Henry J. Kaiser,et al. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation. , 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[87] D. C. Henckel,et al. Case report. , 1995, Journal.
[88] L Wallden,et al. Need for standardization , 1970 .